Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Acta Med Okayama ; 77(1): 65-70, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36849147

RESUMO

We investigated the effects of celecoxib combined with (-)-epigallocatechin-3-gallate (EGCG) or polyphenon E in a cisplatin-induced lung tumorigenesis model. Four-week-old female A/J mice were divided into seven groups: (i) Control, (ii) 150 mg/kg celecoxib (150Cel), (iii) 1,500 mg/kg celecoxib (1500Cel), (iv) EGCG+150 mg/kg celecoxib (EGCG+150Cel), (v) EGCG+1,500 mg/kg celecoxib (EGCG+1500Cel), (vi) polyphenon E+150 mg/kg celecoxib (PolyE+150Cel), and (vii) polyphenon E+1,500 mg/kg celecoxib (PolyE+1500Cel). All mice were administered cisplatin (1.62 mg/kg of body weight, i.p.) 1×/week for 10 weeks and sacrificed at week 30; the numbers of tumors on the lung surface were then determined. The tumor incidence and multiplicity (no. of tumors/mouse, mean±SD) were respectively 95% and 2.15±1.50 in Control, 95% and 2.10±1.29 in 150Cel, 86% and 1.67±1.20 in 1500Cel, 71% and 1.38±1.24 in EGCG+150Cel, 67% and 1.29±1.38 in EGCG+1500Cel, 80% and 1.95±1.36 in PolyE+150Cel, and 65% and 1.05±0.10 in PolyE+1500Cel. The combination of high-dose celecoxib with EGCG or polyphenon E significantly reduced multiplicity in cisplatin-induced lung tumors.


Assuntos
Cisplatino , Inibidores de Ciclo-Oxigenase 2 , Animais , Feminino , Camundongos , Anti-Inflamatórios não Esteroides , Carcinogênese/induzido quimicamente , Celecoxib/farmacologia , Celecoxib/uso terapêutico , Inibidores de Ciclo-Oxigenase 2/farmacologia , Pulmão
2.
BMC Complement Med Ther ; 20(1): 136, 2020 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-32375753

RESUMO

BACKGROUND: Type 2 diabetes mellitus is characterized by insulin resistance and pancreatic ß-cell dysfunction. A decrease in ß-cell mass, which occurs during the progression of Type 2 diabetes mellitus, contributes to impaired insulin secretion. Mulberry leaves contain various nutritional components that exert anti-diabetic and anti-atherogenic effects. The present study analyzed the effects of mulberry leaf intake on pancreatic ß-cells to clarify the mechanisms underlying its anti-diabetic function. METHODS: Mulberry leaves (Morus alba L.) were dried at 180 °C for 8 s in a hot-air mill and fed to obesity/Type 2 diabetes mellitus db/db mouse models at 5% (w/w) as part of a normal diet from 7 to 10, 15, or 20 weeks of age. An intraperitoneal glucose tolerance test was then performed on the mice. To evaluate the ß-cell mass, the pancreas was subjected to immunohistological analysis with an anti-insulin antibody. A TUNEL assay and immunohistological analysis with a proliferation marker was also performed. Expression levels of endoplasmic reticulum stress-responsible genes and proliferation markers were assessed by quantitative RT-PCR. RESULTS: Intake of mulberry leaves maintained the ß-cell function of db/db mice. Moreover, oral administration of mulberry leaves significantly decreased cell death by reducing endoplasmic reticulum stress in the pancreas. Mulberry leaves significantly increased proliferation of ß-cells and the expression of pancreatic duodenal homeobox1 mRNA in the pancreas. CONCLUSION: Considered together, these results indicate that dietary mulberry leaf administration can maintain insulin levels and pancreatic ß-cell mass, at least in part, by suppressing endoplasmic reticulum stress in Type 2 diabetes mellitus mouse models.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Células Secretoras de Insulina/citologia , Morus , Fitoterapia , Folhas de Planta , Administração Oral , Animais , Glicemia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Modelos Animais de Doenças , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Insulina/sangue , Japão , Camundongos , Camundongos Obesos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA